[1]
|
Bruno, A., Pagani, A., Pulze, L., et al. (2014) Orchestration of Angiogenesis by Immune Cells. Frontiers in Oncology, 4, 131. https://doi.org/10.3389/fonc.2014.00131
|
[2]
|
Shutko, A.N., Shatinina, N.N., Lubotskaia, L.S. and Ekimova, L.P. (1981) Lymphocyte Trophic Function as a Potential Reserve in Improving Results of Tumor Radiotherapy. Meditsinskaia Radiologiia, 26, 39-44. https://www.ncbi.nlm.nih.gov/pubmed/6894957 https://elbrary.ru/contents.asp?titleid=7883
|
[3]
|
Yu, P. and Fu, Y.X. (2006) Tumor-Infiltrating T Lymphocytes: Friends or Foes? Laboratory Investigation, 86, 231-245. https://doi.org/10.1038/labinvest.3700389
|
[4]
|
Ruffell, B., De Nardo, D.G., Affara, N.I. and Coussens, L.M. (2010) Lymphocytes in Cancer Development: Polarization towards Pro-Tumor Immunity. Cytokine & Growth Factor Reviews, 21, 3-10. https://doi.org/10.1016/j.cytogfr.2009.11.002
|
[5]
|
Drapeau, C. (2010) Cracking the Stem Cell Code: Demystifying the Most Dramatic Scientific Breakthrough of Our Times. Sutton Hart Press, Hillsboro.
|
[6]
|
Maltby, S., Freeman, S., Gold, M.J., et al. (2011) Opposing Roles for CD34 in B16 Melanoma Tumor Growth Alter Early Stage Vasculature and Late Stage Immune Cell Infiltration. PLoS ONE, 6, e18160. https://doi.org/10.1371/journal.pone.0018160
|
[7]
|
Rennert, R.C., Sorkin, M., Gargand, R.K. and Gurtner, G.C. (2012) Stem Cell Recruitment after Injury: Lessons for Regenerative Medicine. Regenerative Medicine, 7, 833-850. https://doi.org/10.2217/rme.12.82
|
[8]
|
Zidlik, V., Brychtova, S., Uvirova, M., Ziak, D. and Dvorackova, J. (2015) The Changes of Angiogenesis and Immune Cell Infiltration in the Intra- and Peri-Tumoral Melanoma Microenvironment. International Journal of Molecular Sciences, 16, 7876-7889. https://doi.org/10.3390/ijms16047876
|
[9]
|
Finkin, S., Yuan, D., Stein, I., et al. (2015) Ectopic Lymphoid Structures Function as Microniches for Tumor Progenitor Cells in Hepatocellular Carcinoma. Nature Immunology, 16, 1235-1244. https://doi.org/10.1038/ni.3290
|
[10]
|
Patman, G. (2015) Hepatocellular Carcinoma: Ectopic Lymphoid Structures Promote Carcinogenesis in the Liver. Nature Reviews Gastroenterology & Hepatology, 12, 671. https://doi.org/10.1038/nrgastro.2015.192
|
[11]
|
Ashman, L.K. and Aylett, G.W. (1991) Expression of CD31 Epitopes on Human Lymphocytes: CD31 Monoclonal Antibodies Differentiate between Naive (CD45RA+) and Memory (CD45RA-) CD4-Positive T Cells. Tissue Antigens, 38, 208-212. https://doi.org/10.1111/j.1399-0039.1991.tb01899.x
|
[12]
|
Hur, J., Yang, H.M., Yoon, C.H., et al. (2007) Identification of a Novel Role of T Cells in Postnatal Vasculogenesis. Characterization of Endothelial Progenitor Cell Colonies. Circulation, 116, 1671-1682. https://doi.org/10.1161/CIRCULATIONAHA.107.694778
|
[13]
|
Domea, B., Timar, J., Ladanyi, A., et al. (2008) Circulating Endothelial Cells, Bone Marrow-Derived Endothelial Progenitor Cells and Proangiogenic Hematopoietic Cells in Cancer: From Biology to Therapy. Critical Reviews in Oncology/Hematology, 69, 108-124. https://doi.org/10.1016/j.critrevonc.2008.06.009
|
[14]
|
Yu, H.-K., Lee, H.-J., Choi, H.-N., et al. (2013) Characterization of CD45-/CD31+/CD105+ Circulating Cells in the Peripheral Blood of Patients with Gynecologic Malignancies. Clinical Cancer Research, 19, 5340-5350. https://doi.org/10.1158/1078-0432.CCR-12-3685
|
[15]
|
Kucia, M., Ratajczak, J. and Ratajczak, M.Z. (2005) Bone Marrow as a Source of Circulating CXCR4+ Tissue-Committed Stem Cells. Biology of the Cell, 97, 133-146. https://doi.org/10.1042/BC20040069
|
[16]
|
Shoutko, A.N., Gerasimova, O.A., Ekimova, L.P., et al. (2016) Long-Term Activation of Circulating Liver-Committed Mononuclear Cells after OLT. Journal of Regenerative Medicine, 1, 011. https://jacobspublishers.com/long-term-activation-of-circulating-liver-committed-mon...
|
[17]
|
Xiong, Y., Russell, D.L., McDonald, L.T., Cowart, L.A. and La Rue, A.C. (2017) Hematopoietic Stem Cell-Derived Adipocytes Promote Tumor Growth and Cancer Cell Migration. International Journal of Cancer Research and Molecular Mechanisms, 3.
|
[18]
|
Templeton, A.J., McNamara, M.G., Seruga, B., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. https://doi.org/10.1093/jnci/dju124
|
[19]
|
Cho, U., Park, H.S., Im, S.Y., et al. (2018) Prognostic Value of Systemic Inflammatory Markers and Development of a Nomogram in Breast Cancer. PLoS ONE, 13, e0200936. https://doi.org/10.1371/journal.pone.0200936
|
[20]
|
da Costa, J.P., Vitorino, R., Silva, G.M., et al. (2016) A Synopsis on Aging—Theories, Mechanisms and Future Prospects. Ageing Research Reviews, 29, 90-112. https://doi.org/10.1016/j.arr.2016.06.005
|
[21]
|
Clegg, A., Young, J., Iliffe, S., Rikkert, M.O. and Rockwood, K. (2013) Frailty in Older People. The Lancet, 381, 752-762. https://doi.org/10.1016/S0140-6736(12)62167-9
|
[22]
|
Drew, W., Wilson, D. and Sapey, E. (2017) Frailty and the Immune System. Journal of Ageing Research and Health Care, 2, 1-14. https://doi.org/10.14302/issn.2474-7785.jarh-17-1578
|
[23]
|
Bengtson, V.L., Gans, D., Putney, N.M. and Silverstein, M. (2009) Theories about Age and Aging. In: Bengtson, V.L., Silverstein, M., Putney, N.M. and Gans, D., Eds., Handbook of Theories of Aging, Gans Springer Publishing Company, New York, 3-24. http://lghttp.48653.nexcesscdn.net/80223CF/springer-static/media/samplecha pters/9780826129420/9780826129420_chapter.pdf
|
[24]
|
Sun, L., Brown, R., Chen, S., Zhuge, Q. and Su, D.M. (2012) Aging Induced Decline in T-Lymphopoiesis Is Primarily Dependent on Status of Progenitor Niches in the Bone Marrow and Thymus. Aging, 4, 606-619. https://doi.org/10.18632/aging.100487
|
[25]
|
Malkiewicz, A. and Dziedzic, M. (2012) Aging Bone Marrow Reconversion-Imaging of Physiological Changes in Bone Marrow. Polish Journal of Radiology, 77, 45-50. https://doi.org/10.12659/PJR.883628
|
[26]
|
Moresi, R., Tesei, S., Costarelli, L., et al. (2005) Age- and Gender-Related Alterations of the Number and Clonogenic Capacity of Circulating CD34+ Progenitor Cells. Biogerontology, 6, 185-192. https://doi.org/10.1007/s10522-005-7954-5
|
[27]
|
Al Mheid, I., Hayek, S.S., Ko, Y.A., et al. (2016) Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors. Circulation Research, 119, 801-809. https://doi.org/10.1161/CIRCRESAHA.116.308461
|
[28]
|
Chen, X., Mao, G. and Leng, S.X. (2014) Frailty Syndrome: An Overview. Clinical Interventions in Aging, 9, 433-441.
|
[29]
|
Gajraa, A., Klepinb, H.D., Fengc, T., et al. (2015) Predictors of Chemotherapy Dose Reduction at First Cycle in Patients Age 65 Years and Older with Solid Tumors. Journal of Geriatric Oncology, 6, 133-140.
|
[30]
|
Li, J., Chen, Q., Luo, X., Hong, J., et al. (2015) Neutrophil-to-Lymphocyte Ratio Positively Correlates to Age in Healthy Population. Journal of Clinical Laboratory Analysis, 29, 437-443. https://doi.org/10.1002/jcla.21791
|
[31]
|
Mizock, B.A. (2009) The Multiple Organ Dysfunction Syndrome. Disease-A-Month, 55, 476-526. https://doi.org/10.1016/j.disamonth.2009.04.002
|
[32]
|
Nickson, C. (2016) Multi-Organ Dysfunction Syndrome (MODS). Life in the Fastlane. https://lifeinthefastlane.com/ccc/multi-organ-dysfunction-syndrome-mods/
|
[33]
|
Manson, J., Cole, M.E., De’Ath, H.D., et al. (2016) Early Changes within the Lymphocyte Population Are Associated with the Development of Multiple Organ Dysfunction Syndrome in Trauma Patients. Critical Care, 20, 176. https://doi.org/10.1186/s13054-016-1341-2
|
[34]
|
Arias, E., Rostron, B.L. and Tejada-Vera, B. (2010) United States Life Tables, 2006. National Vital Statistics Reports, 58, 1-40. https://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_10.pdf
|
[35]
|
Weon, B.M. and Je, J.H. (2012) Trends in Scale and Shape of Survival Curves. Scientific Reports, 2, 504. https://doi.org/10.1038/srep00504
|
[36]
|
Williams, D.E. (2014) National Population Projections: 2012-Based Reference Volume Series PP2. Chapter 5: Mortality, 2012-Based NPP Reference Volume. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/pop...
|
[37]
|
Veerbeek, J.H.W., Nikkels, P.G.J., Torrance, H.L., et al. (2014) Placental Pathology in Early Intrauterine Growth Restriction Associated with Maternal Hypertension. Placenta, 35, 696-701. https://doi.org/10.1016/j.placenta.2014.06.375
|
[38]
|
Harmon, A.C., Cornelius, D.C., Amaral, L.M., et al. (2016) The Role of Inflammation in the Pathology of Preeclampsia. Clinical Science, 130, 409-419. https://doi.org/10.1042/CS20150702
|
[39]
|
Luppi, P., Powers, R.W., Verma, V., et al. (2010) Maternal Circulating CD34+ VEGFR-2+ and CD133+ VEGFR-2+ Progenitor Cells Increase during Normal Pregnancy But Are Reduced in Women with Preeclampsia. Reproductive Sciences, 17, 643-652. https://doi.org/10.1177/1933719110366164
|
[40]
|
Cornelius, D.C. (2018) Preeclampsia: From Inflammation to Immunoregulation. Clinical Medicine Insights: Blood Disorders, 11, 1179545X17752325.
|
[41]
|
Uzan, J., Carbonnel, M., Piconne, O., Asmar, R. and Ayoubi, J.-M. (2011) Pre-Eclampsia: Pathophysiology, Diagnosis, and Management. Vascular Health and Risk Management, 7, 467-474.
|
[42]
|
Skjaerven, R., Wilcox, A.J., Klungsøyr, K., et al. (2012) Cardiovascular Mortality after Pre-Eclampsia in One Child Mothers: Prospective, Population Based Cohort Study. BMJ, 345, e7677. https://doi.org/10.1136/bmj.e7677
|
[43]
|
CDC (Centers for Disease Control), All Females by Age Group (2015) 2015 Women’s Health CDC. Leading Causes of Death (LCOD) by Age Group, All Females-United States, (Current Listing). https://www.cdc.gov/women/lcod/2015/all-females/index.htm
|
[44]
|
Muzzio, D.O., Ziegler, K.B., Ehrhardt, J., Zygmunt, M. and Jensen, F. (2016) Marginal Zone B Cells Emerge as a Critical Component of Pregnancy Well-Being. Reproduction, 151, 29-37. https://doi.org/10.1530/REP-15-0274
|
[45]
|
Cofre, J. and Abdelhay, E. (2017) Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon. Scientific World Journal (Hindawi), 2017, Article ID: 3578090. https://doi.org/10.1155/2017/3578090
|
[46]
|
de Lima, T.M., Lima, M.M., Almeida, D.C., Mendonça, J.R. and Curi, R. (2005) Cachexia Induced by Walker 256 Tumor Growth Causes Rat Lymphocyte Death. Cancer Immunology, Immunotherapy, 54, 179-186. https://doi.org/10.1007/s00262-004-0570-4
|
[47]
|
de Lima, C., Alves, L.E., Iagher, F., et al. (2008) Anaerobic Exercise Reduces Tumor Growth, Cancer Cachexia and Increases Macrophage and Lymphocyte Response in Walker 256 Tumor-Bearing. European Journal of Applied Physiology, 104, 957-964. https://doi.org/10.1007/s00421-008-0849-9
|
[48]
|
Vanhoutte, G., van de Wiel, M., Wouters, K., et al. (2016) Cachexia in Cancer: What Is in the Definition? BMJ Open Gastroenterology, 3, e000097. https://doi.org/10.1136/bmjgast-2016-000097
|
[49]
|
Sepesi, B., Cuentes, E.P., Canales, J.R., et al. (2017) Tumor-Infiltrating Lymphocytes and Overall Survival in surgically Resected Stage II and III Nonesmall Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics (IJROBP), 98, 223. https://doi.org/10.1016/j.ijrobp.2017.01.060
|
[50]
|
Eerola, A.-K., Soini, Y. and Paakko, P.A. (2000) High Number of Tumor-Infiltrating Lymphocytes Are Associated with a Small Tumor Size, Low Tumor Stage, and a Favorable Prognosis in Operated Small Cell Lung Carcinoma. Clinical Cancer Research, 6, 1875-1881.
|
[51]
|
Rathore, A.S., Goel, M.M., Makker, A., Kumar, S. and Srivastava, A.N. (2013) Prognostic Impact of CD3 Tumor Infiltrating Lymphocytes in Triple-Negative Breast Cancer. Indian Journal of Clinical Practice, 24, 376-389. http://medind.nic.in/iaa/t13/i9/iaat13i9p376.pdf
|
[52]
|
Bromwich, E.J., Mc Ardle, P.A., Canna, K., et al. (2003) The Relationship between T-Lymphocyte Infiltration, Stage, Tumour Grade and Survival in Patients Undergoing Curative Surgery for Renal Cell Cancer. British Journal of Cancer, 89, 1906-1908.
|
[53]
|
Carvalho, M.I., Pires, I., Dias, M., et al. (2015) Intratumoral CD3+ T-lymphocytes Immunoexpression and Its Association With c-kit, Angiogenesis, and Overall Survival in Malignant Canine Mammary Tumor. Analytical Cellular Pathology, 6, Article ID: 920409.
|
[54]
|
Mao, Y., Qu, Q., Chen, X., et al. (2016) The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0152500. https://doi.org/10.1371/journal.pone.0152500
|
[55]
|
Patman, G. (2015) Ectopic Lymphoid Structures Promote Carcinogenesis in the Liver Nature Reviews. Gastroenterology & Hepatology, 12, 671. https://doi.org/10.1038/nrgastro.2015.192
|
[56]
|
Sautès-Fridman, C. and Fridman, W.H. (2016) TLS in Tumors: What Lies Within. Trends in Immunology, 37, 1-2. https://doi.org/10.1016/j.it.2015.12.001
|
[57]
|
Colbeck, E.J., Ager, A., Gallimore, A. and Jones, G.W. (2017) Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease? Frontiers in Immunology, 8, 1830. https://doi.org/10.3389/fimmu.2017.01830
|
[58]
|
Calderaro, J., Petitprez, F., Becht, E., et al. (2018) Intra-Tumoral Tertiary Lymphoid Structures Area Associated with a Low Risk of Early Recurrence of Hepatocellular Carcinoma. Journal of Hepatology, 70, 58-65. https://doi.org/10.1016/j.jhep.2018.09.003
|
[59]
|
Habner, B.A. (2011) General Principles of Cancer Chemotherapy. In: Brunton, L.L., Ed., Goodman and Gilman’s the Pharmacological Basis of Therapeutics, 12 Edition, McGraw Medical, New York, 1667-1670.
|
[60]
|
Berreta, G. (1983) Cancer Chemotherapy Regimens. Farmitalia Carlo Erba, Milano.
|
[61]
|
Liesveld, J.L., Rubin, Ph. and Constine, L.S. (2014) Hematopoietic System. In: Rubin, Ph., Constine, L.S. and Marks, L.B., Eds., Adverse Late Effects of Cancer Treatment, Vol. 2: Normal Tissue Specific Sites and Systems, Springer Verlag, Heidelberg, 623-656. https://doi.org/10.1007/978-3-540-75863-1_24
|
[62]
|
Kopjar, N., Kasuba, V., Rozgaj, R., et al. (2009) The Genotoxic Risk in Health Care Workers Occupationally Exposed to Cytotoxic Drugs—A Comprehensive Evaluation by the SCE Assay. Journal of Environmental Science and Health, Part A, 44, 462-79. https://doi.org/10.1080/10934520902719845
|
[63]
|
Greaves, P. (2012) Small Intestine. In: Greaves, P., Ed., Histopathology of Preclinical Toxicity Studies, Interpretation and Relevance in Drug Safety Studies, Elsevier AP, Amsterdam/Boston/Heidelberg, London, 372-391.
|
[64]
|
Swift, L.H. and Golsteyn, R.M. (2014) Genotoxicanti-Cancer Agents and Their Relationship to DNA Damage, Mitosis, and Checkpoint Adaptation in Proliferating Cancer Cells. International Journal of Molecular Sciences, 15, 3403-3431. https://doi.org/10.3390/ijms15033403
|
[65]
|
Arnon, J., Meirow, D., Lewis-Roness, H. and Ornoy, A. (2001) Genetic and Teratogenic Effects of Cancer Treatments on Gametes and Embryos. Human Reproduction Update, 7, 394-403. https://doi.org/10.1093/humupd/7.4.394
|
[66]
|
Vyas, D., Laput, G. and Vyas, A.K. (2014) Chemotherapy-Enhanced Inflammation May Lead to the Failure of Therapy and Metastasis. OncoTargets and Therapy, 7, 1015-1023. https://doi.org/10.2147/OTT.S60114
|
[67]
|
American Cancer Society (2016) Cancer Treatment & Survivorship Facts & Figures 2016-2017. Estimated Numbers of Cancer Survivors by State as of January 1, Atlanta. https://www.cancer.org/.../cancer-org/.../cancer-facts-and.../c
|
[68]
|
Guillerman, R.P. (2013) Marrow: Red, Yellow and Bad. Pediatric Radiology, 43, 181-192. https://doi.org/10.1007/s00247-012-2582-0
|
[69]
|
Liu, L.-T., Chen, Q.-Y., Tang, L.-Q., et al. (2018) The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients. Cancer Research and Treatment, 50, 19-29.
|
[70]
|
Brower, V. (2013) Tracking Chemotherapy’s Effects on Secondary Cancers. JNCI, 105, 1421-1422. https://doi.org/10.1093/jnci/djt273
|
[71]
|
Marsh, J.C. (1979) Comparison of the Sensitivities of Human, Canine, and Murine Hematopoietic Precursor Cells to Adriamycin and n-Trifluoroacetyladriamycin-14 valerate 1. Cancer Research, 39, 360-364. http://cancerres.aacrjournals.org/content/canres/39/2_Part_1/360.full.pdf
|
[72]
|
Hurria, A. and Lichtman, S.M. (2008) Clinical Pharmacology of Cancer Therapies in Older Adults. British Journal of Cancer, 98, 517-522. https://doi.org/10.1038/sj.bjc.6604201
|
[73]
|
Siegel, M.J. (2011) MRI of Bone Marrow. 169-179. https://pdfs.semanticscholar.org/69ec/de155073c21602f1ac1c76a18bcf144ba924.pdf
|
[74]
|
Richardson, R.B. (2009) Ionizing Radiation and Aging: Rejuvenating an Old Idea. Aging (Albany NY), 1, 887-902. https://doi.org/10.18632/aging.100081
|
[75]
|
Richardson, R.B., Allan, D.S. and Le, Y. (2014) Greater Organ Involution in Highly Proliferative Tissues Associated with the Early Onset and Acceleration of Ageing in Humans. Experimental Gerontology, 55, 80-91. https://doi.org/10.1016/j.exger.2014.03.015
|
[76]
|
Braga, S. (2011) Why Do Our Patients Get Chemotherapy until the End of Life? Annals of Oncology, 22-23, 45-48. https://doi.org/10.1093/annonc/mdr416
|
[77]
|
Karim, S.M., Zekri, J., Abdelghany, E., et al. (2015) Time from Last Chemotherapy to Death and Its Correlation with the End of Life Care in a Referral Hospital. Indian Journal of Medical and Paediatric Oncology, 36, 55-59. https://doi.org/10.4103/0971-5851.151792
|
[78]
|
Bailey, C.H., Jameson, G., Sima, C.E., et al. (2012) Progression-Free Survival Decreases with Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials. Journal of Cancer, 3, 7-13. https://doi.org/10.7150/jca.3.7
|
[79]
|
(2018) Common Terminology Criteria for Adverse Events (CTCAE). Protocol Development, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD). CTCAE v5.0 Clean, Tracked, and Mapping Document (Excel) (November 27, 2017). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50
|
[80]
|
Shoutko, A.N. and Mus, V.F. (2018) Potential of Hematopoietic Stem Cells and Mitotic Activity in Peripheral Lymphocytes to Predict Life Expectancy of Patients with Metastatic Non-Small Cell Lung Cancer after Conventional Therapy. Advances in Molecular Imaging (AMI), 8, 25-37.
|
[81]
|
Shoutko, A.N. and Ekimova, L.P. (2014) Lymphocytopenia Can Contribute in Common Benefit of Cytotoxic Therapy of Cancer. Inter-Medical, 3, 5-13. http://www.inter-medical.ru/files/Archiv/26-27
|
[82]
|
Shoutko, A.N., Gerasimova, O.A., Ekimova, L.P., et al. (2017) Lymphocyte Reproductive Activity Normalized to Numbers of Hematopoietic Stem Cells in Blood and Rate of Death in Fatal Diseases. International Journal of Genetics and Genomics, 5, 54-62. https://doi.org/10.11648/j.ijgg.20170505.12
|
[83]
|
Shoutko, A., Ekimova, L., Mus, V. and Sokurenko, V. (2012) Fluctuations of CD34+ Cells Number in Blood of Cancer Patients during Final Year of Life. Medical and Health Science Journal, 13, 7-13.
|
[84]
|
Wao, H., Mhaskar, R., Kumar, A., Miladinovic, B. and Djulbegovic, B. (2013) Survival of Patients with Non-Small Cell Lung Cancer without Treatment: A Systematic Review and Meta-Analysis. Systematic Reviews, 2, 10. https://doi.org/10.1186/2046-4053-2-10 http://www.systematicreviewsjournal.com/content/2/1/10 https://doi.org/10.1186/2046-4053-2-10
|
[85]
|
Pallis, A.G., Gridelli, C., Wedding, U., Faivre-Finn, C., Veronesi, G., Jaklitsch, M., Luciani, A. and O’Brien, M. (2014) Management of Elderly Patients with NSCLC; Updated Expert’s Opinion Paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Annals of Oncology, 25, 1270-1283. https://doi.org/10.1093/annonc/mdu022
|
[86]
|
Baker, H. (2015) Overtreatment in Stage IV Lung Cancer in the USA. The Lancet Oncology, 16, e532. https://doi.org/10.1016/S1470-2045(15)00383-6
|
[87]
|
Koshy, M., Malik, R., Mahmood, U., Husain, Z., Weichselbaum, R.R. and Sher, D.J. (2015) Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer. JNCI: Journal of the National Cancer Institute, 107, djv278. https://doi.org/10.1093/jnci/djv278
|
[88]
|
Light, D. and Lexchin, J. (2015) Why Do Cancer Drugs Get Such an Easy Ride? BMJ, 350, h2068. https://doi.org/10.1136/bmj.h2068
|
[89]
|
John, S. and Broggio, J. (2019) National Statistic. Dataset: Cancer Survival in England. Adults Diagnosed. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcar/c onditionsanddiseases/datasets/cancersurvivalratescancersurvivalinengla ndadultsdiagnosed
|
[90]
|
SEER Cancer Statistics Review (CSR) 1975-2015. https://seer.cancer.gov/csr/1975_2015/revisions.html
|
[91]
|
Sacdalan, D.B., Lucero, J.A. and Sacdalan, D.L. (2018) Prognostic Utility of Baseline Neutrophil-to-Lymphocyte Ratio in Patients Receiving Immune Checkpoint Inhibitors: A Review and Meta-Analysis. OncoTargets and Therapy, 11, 955-965. https://doi.org/10.2147/OTT.S153290
|
[92]
|
Shibutani, M., Maeda, K., Nagahara, H., et al. (2017) Prognostic Significance of the Preoperative Lymphocyte-to-Monocyte Ratio in Patients with Colorectal Cancer. Oncology Letters, 13, 1000-1006. https://doi.org/10.3892/ol.2016.5487
|
[93]
|
Moschetta, M., Uccello, M., Kasenda, B., et al. (2017) Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade. BioMed Research International, 2017, Article ID: 1506824. https://doi.org/10.1155/2017/1506824
|
[94]
|
Abdellatif, H. and Shiha, G. (2018) PD-L1 Expression on Circulating CD34+ Hematopoietic Stem Cells Closely Correlated with t-Cell Apoptosis in Chronic Hepatitis C Infected Patients. International Journal of Stem Cells, 11, 78-86. https://doi.org/10.15283/ijsc17047
|
[95]
|
Lissoni, P., Brivio, F., Fumagalli, L., et al. (2009) Effects of the Conventional Antitumor Therapies Surgery, Chemotherapy, Radiotherapy and Immunotherapy on Regulatory T Lymphocytes in Cancer Patients. Anticancer Research, 29, 1847-1852.
|
[96]
|
Chaudhary, B. and Elkord, E. (2016) Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel), 4, 28. https://doi.org/10.3390/vaccines4030028
|
[97]
|
Xu, C., Yang, S.P., Zhang, Y., et al. (2018) Neutropenia During the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area. Cancer Research and Treatment, 50, 777-790. https://doi.org/10.4143/crt.2017.255
|
[98]
|
Du, X., Tang, F., Liu, M., et al. (2018) A Reappraisal of CTLA-4 Checkpoint Blockade in Cancer Immunotherapy. Cell Research, 28, 416-432.
|
[99]
|
Hryniewicki, A.T., Wang, C., Shatsky, R.A. and Coyne, C.J. (2018) Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians. Journal of Emergency Medicine, 55, 489-502. https://doi.org/10.1016/j.jemermed.2018.07.005
|
[100]
|
Harding, C., Pompei, F. and Wilson, R. (2012) Peak and Decline in Cancer at Old Ages. Cancer, 118, 1371-1386. https://doi.org/10.1002/cncr.26376
|
[101]
|
National Center for Health Statistics (2016) LCWK1 Deaths, Percent of Total Deaths, and Death Rates for the 15 Leading Causes of Death in 5-Year Age Groups, by Race and Hispanic Origin, and Sex: United States. https://www.cdc.gov/nchs/data/dvs/lcwk/lcwk1_hr_2016.pdf
|
[102]
|
Rivard, A., Fabre, J.-E., Silver, M., et al. (1999) Age-Dependent Impairment of Angiogenesis. Circulation, 99, 111-120. https://doi.org/10.1161/01.CIR.99.1.111
|
[103]
|
Weedon-Fekjaer, H., Lindqvist, B.H., Vatten, L.J., Aalen, O.O. and Tretli, S. (2008) Breast Cancer Tumor Growth Estimated through Mammography Screening Data. Breast Cancer Research, 10, R41. https://doi.org/10.1186/bcr2092
|
[104]
|
Natale, G. and Bocci, G. (2017) Tumor Dormancy, Angiogenesis and Metronomic Chemotherapy. In: Wang, Y. and Crea, F., Eds., Tumor Dormancy and Recurrence, Humana Press, Springer Int. Publ., Cham, 31-50. https://doi.org/10.1007/978-3-319-59242-8_3
|
[105]
|
Dorshkind, K., Montecino-Rodriguez, E. and Signer, R.A. (2009) The Ageing Immune System: Is It Ever Too Old to Become Young Again? Nature Reviews Immunology, 9, 57-62. https://doi.org/10.1038/nri2471
|
[106]
|
Franceschi, C., Capri, M., Monti, D., et al. (2007) Inflammaging and Anti-Inflammaging: A Systemic Perspective on Aging and Longevity Emerged from Studies in Humans. Mechanisms of Ageing and Development, 128, 92-105. https://doi.org/10.1016/j.mad.2006.11.016
|
[107]
|
Shoutko, A.N. and Ekimova, L.P. (2014) The Impact of Middle Age on the Viability of Patients with Nonmalignant and Malignant Diseases. Cancer Research Journal, 2, 114-120. https://doi.org/10.11648/j.crj.20140206.14
|
[108]
|
Propert, K.J. and Anderson, J.R. (1988) Assessing the Effect of Toxicity on Prognosis: Methods of Analysis and Interpretation. JCO, 6, 868-870. https://doi.org/10.1200/JCO.1988.6.5.868
|
[109]
|
Tewari, K.S., Java, J.J., Gatcliffe, T.A., Bookman, M.A. and Monk, B.J. (2014) Chemotherapy-Induced Neutropenia as a Biomarker of Survival in Advanced Ovarian Carcinoma: An Exploratory Study of the Gynecologic Oncology Group. Gynecologic Oncology, 133, 439-445. https://doi.org/10.1016/j.ygyno.2014.03.013
|
[110]
|
Su, Z., Mao, Y.-P., OuYang, P.-Y., et al. (2015) Leucopenia and Treatment Efficacy in Advanced Nasopharyngeal. BMC Cancer, 15, 429.
|
[111]
|
van Zant, G. and Liang, Y. (2012) Concise Review: Hematopoietic Stem Cell Aging, Life Span, and Transplantation. Stem Cells Translational Medicine, 1, 651-657. https://doi.org/10.5966/sctm.2012-0033
|
[112]
|
Zhu, L., Zhou, L.K., Xue, M., et al. (2009) Factors Impacting Yield of CD34(+) Cells from Healthy Donors Mobilized with rhG-CSF. Journal of Experimental Hematology, 17, 1541-45.
|
[113]
|
Colmegna, I., Diaz-Borjon, A., Fujii, H., et al. (2008) Defective Proliferative Capacity and Accelerated Telomeric Loss of Hematopoietic Progenitor Cells in Rheumatoid Arthritis. Arthritis & Rheumatology, 58, 990. https://doi.org/10.1002/art.23287
|
[114]
|
Pang, W.W., Price, E.A., Sahoo, D., et al. (2011) Human Bone Marrow Hematopoietic Stem Cells Are Increased in Frequency and Myeloid-Biased with Age. Proceedings of the National Academy of Sciences, 108, 20012-20017. https://doi.org/10.1073/pnas.1116110108
|
[115]
|
Shoutko, A.N., Yurkova, L.E., Borodulya, K.S. and Ekimova, L.P. (2016) Protracted Half-Body Irradiation Instead of Chemotherapy: Life Span and Lymphocytopenia in Relapsed Ovarian Cancer. International Journal of Tumor Therapy, 5, 1-7.
|
[116]
|
Yoon, J.-H., Kim, H.-J. and Min, W.-S. (2017) Comparison of the Effects of Early Intensified Induction Chemotherapy and Standard 3+7 Chemotherapy in Adult Patients with Acute Myeloid Leukemia. Blood Research, 52, 174-183. https://doi.org/10.5045/br.2017.52.3.17
|
[117]
|
Shoutko, A.N., Yurkova, L.E., Borodulya, K.S., Ekimova, L.P. and Matyurin K.S. (2017) Competitive Principal of Tumor Control in Radiological Clinic. Radiology and Diagnostic Imaging, 1, 1-2.
|
[118]
|
Barnett, G.C., West, C.M., Dunning, A.M., et al. (2009) Normal Tissue Reactions to Radiotherapy: Towards Tailoring Treatment Dose by Genotype. Nature Reviews Cancer, 9, 134-142. https://doi.org/10.1038/nrc2587
|
[119]
|
Bracci, L., Schiavoni, G., Sistigu, A. and Belardelli, F. (2014) Chemotherapeutic Agents Stimulate Both the Innate and Adaptive Arms of the Immune System. Cell Death and Differentiation, 21, 15-25.
|
[120]
|
ElKaffas, A., Giles, A. and Czarnota, G.J. (2013) Dose-Dependent Response of Tumor Vasculature to Radiation Therapy in Combination with Sunitinib Depicted by Threedimensional High-Frequency Power Doppler Ultrasound. Angiogenesis, 16, 443-454.
|
[121]
|
El Kaffas, A., Gangeh, M.J., Farhat, G., et al. (2018) Tumour Vascular Shutdown and Cell Death Following Ultrasound-Microbubble Enhanced Radiation Therapy. Theranostics, 8, 314-327. https://doi.org/10.7150/thno.19010
|
[122]
|
Jayson, G.C., Hicklin, D.J. and Ellis, L.M. (2012) Antiangiogenic Therapy-Evolving View Based on Clinical Trial Results. Nature Reviews Clinical Oncology, 9, 297-303. https://doi.org/10.1038/nrclinonc.2012.8
|
[123]
|
Guo, S. and Deng, C.X. (2018) Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation. International Journal of Biological Sciences, 14, 2083-2093. http://www.ijbs.com/v14p2083.htm https://doi.org/10.7150/ijbs.25720
|
[124]
|
Kojima, S., Tsukimoto, M., Shimura, N., et al. (2017) Treatment of Cancer and Inflammation with Low-Dose Ionizing Radiation: Three Case Reports. Dose Response, 15, 1559325817697531. https://doi.org/10.1177/1559325817697531
|
[125]
|
Shoutko, A.N., Yurkova, L.E., Borodulya, K.S. and Ekimova, L.P. (2015) Lymphocytopenia and Cytotoxic Therapy in Patients with Advanced Ovarian Cancer. Cancer Research Journal, 3, 47-51. https://doi.org/10.11648/j.crj.20150303.11
|
[126]
|
Hayman, J.A., Callahan, J.W., Herschtal, A., et al. (2011) Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using Flt-Pet Imaging. International Journal of Radiation Oncology, Biology, Physics, 79, 847-852. https://doi.org/10.1016/j.ijrobp.2009.11.040
|
[127]
|
Garau, M.M., Calduch, A.L. and López, E.C. (2011) Radiobiology of the Acute Radiation Syndrome. Reports of Practical Oncology and Radiotherapy, 16, 123-130. https://doi.org/10.1016/j.rpor.2011.06.001
|
[128]
|
Di Carlo, A.L., Maher, C., Hick, J.L., et al. (2011) Radiation Injury after a Nuclear Detonation: Medical Consequences and the Need for Scarce Resources Allocation. Disaster Medicine and Public Health Preparedness, 5, 532-544.
|
[129]
|
Wang, Z., Chen, J.-Q., Liu, J.-L. and Qin, X.-G. (2016) Serious Neutropenia Following Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Case Report. Oncology Letters, 11, 1597-1599. https://doi.org/10.3892/ol.2016.4077
|
[130]
|
Kasi, P.M., Tawbi, H.A., Oddis, C.V. and Kulkarni, H.S. (2012) Clinical Review: Serious Adverse Events Associated with the Use of Rituximab—A Critical Care Perspective. Critical Care, 16, 231. https://doi.org/10.1186/cc11304
|
[131]
|
Saxena, N.S., Davis, K.L., Inlay, M.A., et al. (2016) High Resolution Mapping of Human Lymphopoiesis Reveals a Common Lymphoid Progenitor (CLP) Population. Blood, 128, 1473. http://www.bloodjournal.org/content/128/22/1473
|
[132]
|
Ahmed, A.S.I., Sheng, M.H.C., Wasnik, S., Baylink, D.J. and Lau, K.-H.W. (2017) Effect of Aging on Stem Cells. World Journal of Experimental Medicine, 20, 1-10. https://doi.org/10.5493/wjem.v7.i1.1
|
[133]
|
Das, R.K., Vernau, L., Grupp, S.A. and Barrett, D.M. (2019) Naive T Cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers. Cancer Discovery, 492-499. https://doi.org/10.1158/2159-8290.CD-18-1314
|
[134]
|
Bracci, L., Schiavoni, G., Sistigu, A. and Belardelli, F. (2014) Immune-Based Mechanisms of Cytotoxic Chemotherapy: Implications for the Design of Novel and Rationale-Based Combined Treatments against Cancer. Cell Death and Differentiation, 21, 15-25. https://doi.org/10.1038/cdd.2013.67
|
[135]
|
Sakamoto, K. (2004) Radiobiological Bases for Cancer Therapy by Total or Half-Body Irradiation. Nonlinearity in Biology, Toxicology, Medicine, 2, 293-316. https://doi.org/10.1080/15401420490900254
|
[136]
|
Scott, B.R. (2008) Low-Dose-Radiation Stimulated Natural Chemical and Biological Protection against Lung Cancer. Dose Response, 6, 299-318. https://doi.org/10.2203/dose-response.07-025.Scott
|
[137]
|
Cuttler, J.M. (2013) Commentary on Fukushima and Beneficial Effects of Low Radiation. Dose Response, 11, 447-458. https://doi.org/10.2203/dose-response.13-008.Cuttler
|
[138]
|
Kashcheev, V.V., Chekin, S.Y., Maksioutov, M.A., et al. (2015) Incidence and Mortality of Solid Cancer among Emergency Workers of the Chernobyl Accident: Assessment of Radiation Risks for the Follow-Up Period of 1992-2009. Radiation and Environmental Biophysics, 54, 13-23. https://doi.org/10.1007/s00411-014-0572-3
|
[139]
|
Nair, R., Rajan, B., Akiba, S., et al. (2009) Background Radiation and Cancer Incidence in Kerala, India-Karanagappally Cohort Study. Health Physics, 96, 55-66. https://doi.org/10.1097/01.HP.0000327646.54923.11
|
[140]
|
Chen, W.L., Luan, Y.C., Shieh, M.C., et al. (2007) Effects of Cobalt-60 Exposure on Health of Taiwan Residents Suggest New Approach Needed in Radiation Protection. Dose Response, 5, 63-75. https://doi.org/10.2203/dose-response.06-105.Chen
|
[141]
|
Mortazavi, S.M.J. and Karam, P.A. (2013) Natural Radiation: High Background Radiation Areas (HBRAs) of Ramsar. Iran Research Gate, 5/9, 1-7. http://www.sums.ac.ir/~mmortazavi/ramsar.html 5/9/2013
|
[142]
|
Oakley, P.A. (2015) Is Use of Radiation Hormesis the Missing Link to a Better Cancer Treatment? Journal of Cancer Therapy, 6, 601-605. https://doi.org/10.4236/jct.2015.67065
|
[143]
|
Calabrese, E.J. and Mattson, M.P. (2017) How Does Hormesis Impact Biology, Toxicology, and Medicine? NPJ Aging and Mechanisms of Disease, 3, Article No. 13.
|
[144]
|
Calabrese, E.J., Shamoun, D.Y. and Hanekamp, J.C. (2016) The Integration of LNT and Hormesis for Cancer Risk Assessment Optimizes Public Health Protection. Health Physics, 110, 256-259. https://doi.org/10.1097/HP.0000000000000382
|
[145]
|
Calabrese, E. (2017) Mistake Led to Adopting the LNT Model in Toxicology, Says Calabrese. News & Media Relations. https://www.umass.edu/newsoffice/article/mistake-led-adopting-lnt-model-toxicology
|
[146]
|
Robinson, A.B. (2013) Radiation Hormesis, Cancer, and Freedom in American Medicine. Journal of American Physicians and Surgeons, 18, 74-76. http://www.jpands.org/vol18no3/robinson.pdf
|
[147]
|
Weber, W. and Zanzonico, P. (2017) The Controversial Linear No-Threshold Model. Journal of Nuclear Medicine, 58, 7-8. https://doi.org/10.2967/jnumed.116.182667
|
[148]
|
Beyea, J. (2016) Response to, “On the Origins of the Linear No-Threshold (LNT) Dogma by Means of Untruths, Artful Dodges and Blind Faith.” Environmental Research, 148, 527-534. https://doi.org/10.1016/j.envres.2016.01.039
|
[149]
|
Paganini, M. (2012) Linear No-Threshold Model. Physics H190, Spring Selected Lecture. https://documen.site/download/linear-no-threshold-model_pdf
|
[150]
|
Mc Mahon, S.J., Schuemann, J., Paganetti, H. and Prise, K.M. (2016) Mechanistic Modelling of DNA Repair and Cellular Survival Following Radiation-Induced DNA Damage. Scientific Reports, 6, Article No. 33290. https://www.nature.com
|
[151]
|
Kakarougkas, A. and Jeggo, P.A. (2014) DNA DSB Repair Pathway Choice: An Orchestrated Handover Mechanism. The British Journal of Radiology, 87, 20130685. https://doi.org/10.1259/bjr.20130685
|
[152]
|
Kostyrko, K. and Mermod, N. (2016) Assays for DNA Double-Strand Break Repair by Microhomology-Based End-Joining Repair Mechanisms. Nucleic Acids Research, 44, e56. https://doi.org/10.1093/nar/gkv1349
|
[153]
|
Cuttler, J.M., Feinendegen, L.E. and Socol, Y. (2017) Evidence That Lifelong Low Dose Rates of Ionizing Radiation Increase Lifespan in Long- and Short-Lived Dogs. Dose Response, 15, Article ID: 155932581769290. https://doi.org/10.1177/1559325817692903
|
[154]
|
Shoutko, A.N. and Ekimova, L.P. (2014) Abnormal Tissue Proliferation and Life Span Variability in Chronically Irradiated Dogs. Radiation and Environmental Biophysics, 53, 65-72. https://doi.org/10.1007/s00411-013-0504-7
|
[155]
|
Shoutko, A.N. and Ekimova, L.P. (2017) The Effects of Tissue Regenerative Status on Hormesis in Dogs Irradiated during Their Lifespan. Open Journal of Biophysics, 7, 101-115. https://doi.org/10.4236/ojbiphy.2017.73009
|
[156]
|
Xue, Q.-L. (2011) The Frailty Syndrome: Definition and Natural history. Clinics in Geriatric Medicine, 27, 1-15. https://doi.org/10.1016/j.cger.2010.08.009
|
[157]
|
Shoutko, A. and Shatinina, N. (1998) Chronic Cancer—Could It Be? Coherence—International Journal of Integrated Medicine, 2, 36-40. http://www.iaam.nl/coherence/coherence0001.htm
|
[158]
|
Shoutko, A. and Yurkova, L. (2001) Indirect Control of Tumor Growth in Radiotherapy. Coherence—International Journal of Integrated Medicine, 2, 36-40. http://www.iaam.nl/coherence/coherence0001.htm
|
[159]
|
Shoutko, A.N., Ekimova, L.P., Vasilyeva, M.J. and Shatinina, N.N. (2000) Tissue Factors Involved in Cancer Induction. Proceedings of the 5th International Conference on High Level of Natural Radiation and Radon Areas: Radiation Dose and Health Effects, Munich, 4-7 September 2000, 467-470.
|
[160]
|
Janiak, M.K., Wincenciak, M., Cheda, A., Nowosielska, E.M. and Calabrese, E.J. (2017) Cancer Immunotherapy: How Low-Level Ionizing Radiation Can Play a Key Role. Cancer Immunology, Immunotherapy, 66, 819-832. https://doi.org/10.1007/s00262-017-1993-z
|
[161]
|
Fowler, J.F. (2010) 21 Years of Biologically Effective Dose. The British Journal of Radiology, 83, 554-568. https://doi.org/10.1259/bjr/31372149
|